Global Monoclonal Antibodies In Veterinary Health Market Size study & Forecast, by Animal Type (Dogs, Others), by Application (Dermatology, Pain, Others), by End-User (Veterinary Hospitals, Others) and Regional Analysis, 2022-2029

Global Monoclonal Antibodies In Veterinary Health Market Size study & Forecast, by Animal Type (Dogs, Others), by Application (Dermatology, Pain, Others), by End-User (Veterinary Hospitals, Others) and Regional Analysis, 2022-2029

Global Monoclonal Antibodies In Veterinary Health Market is valued at approximately USD 0.68 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.7% over the forecast period 2022-2029. A monoclonal antibody is a type of antibody that is created by cloning a unique white blood cell. Monoclonal antibodies have a monovalent affinity that binds only to the same epitope. Monoclonal antibodies in veterinary health help in binding mono specifically to certain cells or proteins, imitating the animal’s natural response to attack those cells. Factors such as the growing pet population, and increasing expenditure on a pet, coupled with the rising incidences of canine atopic dermatitis are driving the market growth across the globe.

According to the Insurance Information Institute, in 2018, the total expenditure on the pet industry was estimated to account for USD 90.5 billion and the amount is constantly increasing and reached nearly USD 123.6 billion in 2021. Therefore, the increasing expenditure on a pet is leveraging the growth of Monoclonal Antibodies In Veterinary Health Market. In addition, an increasing number of initiatives by government and various private organizations, as well as growing investment in R&D activities are creating various growth prospects for the market development over the forecasting years. However, the lack of awareness and several problems associated with the Monoclonal Antibodies are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Monoclonal Antibodies In Veterinary Health Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the increasing expenditure on animal healthcare, rising number of veterinary clinics and hospitals, and the presence of leading companies. Moreover, Asia Pacific is expected to grow significantly during the forecast period. Factors such as the rising awareness regarding animal healthcare, rising prevalence of diseases in animals, along with the availability of treatment alternatives are bolstering the market demand across the region.

Major market players included in this report are:
Zoetis
Merck & Co, Inc.
Elanco Animal Health
Phibro Animal Health Corporation
Boehringer Ingelheim GmbH
Indian Immunologicals Ltd
Virbac
American Animal Health, Inc.
Hester Biosciences Limited
Colorado Serum Company

Recent Developments in the Market:

in January 2022, Zoetis publicized that its Solensia a product for pain management of osteoarthritis in cats has received the U.S. FDA approval.

In January 2022, Boehringer Ingelheim International GmbH declared the company’s collaboration with MabGenesis, with the objective of developing monoclonal antibodies for canine diseases.
Global Monoclonal Antibodies In Veterinary Health Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage
Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered
Animal Type, Application, End-User, Region
Regional Scope
North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope
Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below.
By Animal Type:
Dogs
Others
By Application:
Dermatology
Pain
Others
By End User:
Veterinary Hospitals
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australi.
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

Zoetis
Merck & Co, Inc.
Elanco Animal Health
Phibro Animal Health Corporation
Boehringer Ingelheim GmbH
Indian Immunologicals Ltd
Virbac
American Animal Health, Inc.
Hester Biosciences Limited
Colorado Serum Company

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.